Khartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops oral small molecule therapies for immunological and chronic diseases
Develops next-generation bispecific ADCs for cancer treatment
Develops therapies to halt fibrosis in multiple organ systems